ES8708127A1 - Procedimiento de preparar hidroxamatos farmaceuticamente activos. - Google Patents

Procedimiento de preparar hidroxamatos farmaceuticamente activos.

Info

Publication number
ES8708127A1
ES8708127A1 ES554125A ES554125A ES8708127A1 ES 8708127 A1 ES8708127 A1 ES 8708127A1 ES 554125 A ES554125 A ES 554125A ES 554125 A ES554125 A ES 554125A ES 8708127 A1 ES8708127 A1 ES 8708127A1
Authority
ES
Spain
Prior art keywords
hydroxamates
modulators
arachidonic acid
metabolic pathways
acid metabolic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES554125A
Other languages
English (en)
Other versions
ES554125A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
USV Pharmaceutical Corp
Original Assignee
USV Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by USV Pharmaceutical Corp filed Critical USV Pharmaceutical Corp
Publication of ES8708127A1 publication Critical patent/ES8708127A1/es
Publication of ES554125A0 publication Critical patent/ES554125A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR HIDROXAMATOS FARMACEUTICAMENTE ACTIVOS. CONSISTE EN HACER REACCIONAR UN ACIDO CARBOXILICO DE FORMULA (II) CON UNA HIDROXILAMINA DE FORMULA (III), EN TETRAHIDROFURANO Y ENTRE 0JC Y LA TEMPERATURA DE REFLUJO, PARA OBTENER UN COMPUESTO DE FORMULA (I) Y SUS SALES FARMACEUTICAMENTE ACEPTABLES. SIENDO: AR, FENILO O NAFTILO; R Y R1, H, CICLOALQUILO INFERIOR Y OTROS; R2, H, ALQUILO INFERIOR Y OTROS; R3 Y R4, H, O ALQUILO INFERIOR; R5, H, ARILO Y OTROS; X E Y, O, S O CR3R4; Z, Z1 Y Z2, CADENA DE ALQUILENO SUSTITUIDA POR H, ALQUILO INFERIOR Y OTROS; N, 0, 1 O 2; Y N1, 1 O 2. SE UTILIZAN COMO ANRTIINFLAMATORIOS Y ANTIALERGICOS.
ES554125A 1985-04-03 1986-04-03 Procedimiento de preparar hidroxamatos farmaceuticamente activos. Expired ES8708127A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71919985A 1985-04-03 1985-04-03
US06/830,798 US4792560A (en) 1985-04-03 1986-02-19 Quinoline hydroxamates and their use as modulators of arachidonic acid metabolic pathways

Publications (2)

Publication Number Publication Date
ES8708127A1 true ES8708127A1 (es) 1987-10-16
ES554125A0 ES554125A0 (es) 1987-10-16

Family

ID=27110043

Family Applications (1)

Application Number Title Priority Date Filing Date
ES554125A Expired ES8708127A1 (es) 1985-04-03 1986-04-03 Procedimiento de preparar hidroxamatos farmaceuticamente activos.

Country Status (7)

Country Link
US (1) US4792560A (es)
EP (1) EP0196674A3 (es)
AU (1) AU5568186A (es)
DK (1) DK150986A (es)
ES (1) ES8708127A1 (es)
FI (1) FI861444A (es)
NO (1) NO861306L (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4607053A (en) * 1984-05-17 1986-08-19 E. R. Squibb & Sons, Inc. Arylhydroxamates useful as antiallergy agents
IE59397B1 (en) * 1985-03-16 1994-02-23 Wellcome Found New aryl derivatives
GB8531839D0 (en) * 1985-12-30 1986-02-05 Wellcome Found Aryl derivatives
US4861798A (en) * 1986-12-29 1989-08-29 Bristol-Myers Company Lipoxygenase inhibitory compounds
US4731382A (en) * 1986-12-29 1988-03-15 Bristol-Myers Company Lipoxygenase inhibitory phenylalkanohydroxamic acids
US5155110A (en) * 1987-10-27 1992-10-13 Warner-Lambert Company Fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition
US4943587A (en) * 1988-05-19 1990-07-24 Warner-Lambert Company Hydroxamate derivatives of selected nonsteroidal antiinflammatory acyl residues and their use for cyclooxygenase and 5-lipoxygenase inhibition
US5112868A (en) * 1988-05-19 1992-05-12 Warner-Lambert Company Hydroxamate derivatives of selected nonsteroidal antiinflammatory acyl residues having cyclooxygenase and 5-lipoxygenase inhibition
US5096919A (en) * 1989-01-05 1992-03-17 Ciba-Geigy Corporation Pyrrolylphenyl-substituted hydroxamic acid derivatives
IL92915A0 (en) * 1989-01-05 1990-09-17 Ciba Geigy Ag Certain pyrrolylphenyl-substituted hydroxamic acid derivatives
US4960787A (en) * 1989-02-06 1990-10-02 Ciba-Geigy Corporation Certain pyrrolyl-substituted hydroxamic acid derivatives
US4981865A (en) * 1989-05-26 1991-01-01 Warner-Lambert Co. N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents
US5112846A (en) * 1989-05-26 1992-05-12 Warner-Lambert Company N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents
US5075330A (en) * 1989-05-26 1991-12-24 Warner-Lambert Co. N-hydroxyamide, N-hydroxythioamide, N-hydroxyurea, and N-hydroxythiourea derivatives of selected NSAIDS as antiinflammatory agents
US5155130A (en) * 1989-08-11 1992-10-13 Ciba-Geigy Corporation Certain benzopyran and benzothiopyran derivatives
US5229516A (en) * 1989-10-27 1993-07-20 American Home Products Corporation Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase
US5017604A (en) * 1990-04-11 1991-05-21 Warner-Lambert Company Novel fenamic acid methyl hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition
US5120758A (en) * 1991-02-08 1992-06-09 Ciba-Geigy Corporation Certain benzodioxole, benzodioxane and benzodioxepin derivatives useful as 5-lipoxygenase inhibitors
US5140047A (en) * 1991-05-03 1992-08-18 Smithkline Beecham Corporation Lipoxygenase inhibitors
US5334600A (en) * 1991-07-30 1994-08-02 Ciba-Geigy Corporation Isoquinolyl substituted hydroxylamine derivatives
US5260316A (en) * 1991-07-30 1993-11-09 Ciba-Geigy Corporation Isoquinolyl substituted hydroxylamine derivatives
US5350761A (en) * 1991-07-30 1994-09-27 Ciba-Geigy Corporation Indolyl substituted hydroxylamine derivatives
US5358955A (en) * 1992-10-30 1994-10-25 Abbott Laboratories Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis
IT1283637B1 (it) * 1996-05-14 1998-04-23 Italfarmaco Spa Composti ad attivita' antinfiammatoria ed immunosoppressiva
US6541661B1 (en) 1999-11-23 2003-04-01 Methylgene, Inc. Inhibitors of histone deacetylase
US20040267015A1 (en) * 2001-04-05 2004-12-30 Ajita Bhat Peptide deformylase inhibitors
US8796330B2 (en) * 2006-12-19 2014-08-05 Methylgene Inc. Inhibitors of histone deacetylase and prodrugs thereof
GB0821010D0 (en) 2008-11-17 2008-12-24 Univ Warwick Plant development control composition
US9593136B2 (en) * 2011-07-01 2017-03-14 The George Washington University Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase
US9636298B2 (en) 2014-01-17 2017-05-02 Methylgene Inc. Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6406688A (es) * 1964-06-05 1965-12-06
BE689347A (es) * 1965-12-09 1967-04-14 Madan Ag
US3481970A (en) * 1967-05-08 1969-12-02 Standard Oil Co Process for preparation of beta-chloromethacrylonitrile
SE363818B (es) * 1968-08-15 1974-02-04 Lilly Co Eli
GB1396726A (en) * 1972-06-15 1975-06-04 Boots Co Ltd Phenylalkanoic acids
IT1046338B (it) * 1974-12-06 1980-06-30 Manetti & Roberts Italo Brit Procedimento per preparare aoido 2,4 isoputil fenil propioidros sanico e combusto intermerio beriesso
NL7614113A (nl) * 1976-12-18 1978-06-20 Akzo Nv Hydroxamzuren.

Also Published As

Publication number Publication date
DK150986A (da) 1986-10-04
FI861444A (fi) 1986-10-04
US4792560A (en) 1988-12-20
EP0196674A2 (en) 1986-10-08
FI861444A0 (fi) 1986-04-03
EP0196674A3 (en) 1988-06-15
ES554125A0 (es) 1987-10-16
NO861306L (no) 1986-10-06
DK150986D0 (da) 1986-04-03
AU5568186A (en) 1986-10-09

Similar Documents

Publication Publication Date Title
ES8708127A1 (es) Procedimiento de preparar hidroxamatos farmaceuticamente activos.
ES2005073A6 (es) Procedimiento para preparar benzamidas y bencenoacetamidas
MY133647A (en) Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
PL314300A1 (en) Peptide-type compounds and their therapeutic application as inhibitors of metalloproteinases
PL319503A1 (en) Peptide compounds and their therapeutic application as inhibitors
ES2040208T3 (es) Pirazolinas insecticidas.
AU6328586A (en) Novel enolamides, pharmaceutical compositions and methods of use thereof for activity as modulators of the arachidonic acid cascade
ZA851552B (en) Benzisoselenazolethiones,processes for their preparation and pharmaceutical products containing these compounds
AU6627286A (en) Electrochemical treatment of lignins
BR0315820A (pt) Inibidores de integrase de hiv, composições farmacêuticas e métodos para a sua utilização
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
ATE41146T1 (de) Irreversible dopamin-b-hydroxylase-inhibitoren.
ES2056983T3 (es) Compuestos para inhibir la biosintesis de metabolitos de acido araquidonico derivados de lipoxigenasa.
AU578295B2 (en) Phenyl-substituted naphthyridines and their use as anti-ulcer drugs
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
ES8403487A1 (es) "procedimiento para la preparacion de n-(2-metoxietil)-noroximorfona".
ES553207A0 (es) Un procedimiento para la preparacion de una octahidroindolizina
ATE86611T1 (de) Topische vorstufen von arzneimitteln zur behandlung von akne und hautkrankheiten.
WO1986007357A2 (en) Cyclopentapyrazole and tetrahydroindazole compounds
ES2000960A6 (es) Un procedimiento para preparar n(1-ciclohexenilmetil-2-pirrolidinilmetil)-8-etilsulfonil-1,5-benzodioxepan-6-carboxamida
UA12244A1 (uk) Засіб для передпосівhої обробки hасіhhя кукурудзи
ES8605584A1 (es) Un procedimiento para preparar foroximitina
ES2000665A6 (es) Un procedimiento para la preparacion de acido 1-etil-6-flouro-1,4-dihidro-4-ceto-7-(trimetilolmetilamino)-quinolin-3-carboxilico
MX9709982A (es) Retinoides de chalcona y uso de los mismos.
ATE39843T1 (de) Verwendung von sekundaeren amidverbindungen zur herstellung von arzneimitteln zur behandlung von dermatologischen entzuendungen.